The global dihydromyricetin market was valued USD XX MN (by revenue) in 2019. The report foresees this market to reach USD XX MN by 2026 and register a CAGR of XX% from 2020 to 2026. By volume, the market was estimated XX KT in 2019 and is expected to reach XX KT by 2026 with a CAGR of XX% (between 2020 and 2026).
Dihydromyricetin is a heteroprotective flavonoid, which is extracted from Hovenia Dulcis. Dihydromyricetin is also known as Ampelopsin. It is used in traditional Chinese, Japanese medicine to treat flu, parasitic infection, liver diseases and for treating a hangover. Dihydromyricetin prevents intoxication, reduces alcohol addiction and shows anti-cancer activity.
- Rising demand from end-users
- Growing adoption of dihydromyricetin to reduce alcoholism
- Availability of substitute products
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of dihydromyricetin.
The broad dihydromyricetin market has been sub-grouped into application. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
- Pharma & Healthcare
- Food & Feed Additives
Furthermore, the report comprises of the geographical segmentation, which mainly focuses on current and forecast demand for dihydromyricetin in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
Europe Dihydromyricetin Market By Revenue (USD MN)
The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the dihydromyricetin market include Wuhan Vanz Pharm, Xi'an Arisun ChemPharm, Xi'an Lyphar Biotech, Xi'an Natural Field Bio-Technique, Xian Sost Biotech, Xian Tonking Biotech, and Yongzhou Huamao Biotechnology
among others. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.
Manufacturing Cost Analysis
The Dihydromyricetin Market Manufacturing Cost Analysis included in the report provides data on raw materials, labor cost and other manufacturing expenses. This analysis assists in cost management and cost regularizing as per the industry trends.
The detailed analysis of the marketing channel prominently used in Dihydromyricetin market is also covered in the report. The data is covered as direct marketing, indirect marketing, and marketing channel development trends.
A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand.